Clonal malignant T cells in these CTCL patients express uniformly high levels of CCR4, but variable to low levels of other skin homing addressins, including CLA, CCR10 and CCR6. The gene discussed is CCR4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.